-
2024-516115-24-00
9
High risk relapsed neuroblastoma (relapsed or progressed after being d
-
2025-522855-25-00
5
Carcinoma, Transitional Cell
-
2025-523010-89-00
3
Pulmonary arterial hypertension
-
2025-524316-11-00
5
Primary Progressive Multiple Sclerosis (PPMS)
-
2024-514754-79-00
4
2026-05-06
Pulmonary Arterial Hypertension (PAH)
-
2024-517943-29-00
5
2026-04-21
Pulmonary Hypertension associated with interstitial lung disease (WHO
-
2025-523533-25-00
10
2026-03-26
Cancer-associated Cachexia
-
2025-521831-35-00
6
2026-02-12
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
-
2025-522767-15-00
5
2026-01-27
Acute Myeloid Leukemia
-
2025-522052-13-00
10
2025-12-24
Framework for Optimizing, Refining, and Unifying Management of HSCT in
-
2024-515245-42-00
3
2025-04-24
Ewing Sarcoma
-
2024-512733-32-00
5
2025-03-31
Acute Myeloid Leukemia (AML)
-
2024-514517-35-00
5
2025-02-27
Acute myeloid leukemia
-
2023-503904-10-00
5
2024-06-07
Sjögren’s Syndrome With Moderate-to-severe Systemic Disease Activity
-
2023-507402-13-00
5
2024-04-03
Multiple myeloma
-
2023-508123-12-00
10
2023-11-03
Post-Acute COVID Syndrome (PACS)
-
2023-509672-42-00
5
2023-02-02
GRIN-related neurodevelopmental disorder
-
2023-507518-28-00
5
2022-09-13
Acute myeloid leukemia
-
2024-514617-35-00
4
2021-12-20
Progressive forms of Multiple Sclerosis
-
2023-510509-17-00
7
2020-06-17
Relapsed and/or refractory Acute Myeloid Leukemia
-
2024-512657-24-00
10
2014-03-27
Acute Lymphoblastic Leukaemia
-
2025-521546-23-00
5
2026-04-21
Secondary progressive multiple sclerosis
-
2025-522232-13-00
4
2026-03-06
Sepsis-associated acute kidney injury (AKI)
-
2024-511101-28-00
4
2026-02-24
Episodic Migraine
Chronic Migraine